Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
Clinical trial NCT06117774 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06117774
- Sponsor
- Amgen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-20
- Primary completion
- 2030-04-20
- Enrollment
- 404
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.